Giuseppe Di Lucca
Azienda Socio Sanitaria Territoriale Lariana(IT)
Publications by Year
Research Areas
Renal cell carcinoma treatment, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Cancer Immunotherapy and Biomarkers, Intensive Care Unit Cognitive Disorders
Most-Cited Works
- → Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study(2020)1,001 cited
- → Effects of environmental factors and agricultural techniques on antioxidantcontent of tomatoes(2003)914 cited
- → Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial(2013)91 cited
- → Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer(2014)89 cited
- → Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial(2018)87 cited
- → Prognostic Factors for Survival inMetastatic Renal Cell Carcinoma:Retrospective Analysis from109 Consecutive Patients(1997)70 cited
- → A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients(2021)35 cited
- → Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19(2021)33 cited
- → Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19(2021)27 cited
- → Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous α-interferon(1994)22 cited